Unlike classic GBM, E-GBM exhibits a different genetic profile, including BRAF V600E mutations, which can influence both its behavior and response to targeted therapies and present the differences between E-GBM and traditional GBM. The gene discussed is BRAF; the disease is glioblastoma.